Observation of circulating tumor cells in patients with lung carcinoma by real-time fluorescent quantitative-PCR approach before and after chemotherapy
返回论文页
|更新时间:2024-01-17
|
Observation of circulating tumor cells in patients with lung carcinoma by real-time fluorescent quantitative-PCR approach before and after chemotherapy
Journal of Chongqing Medical UniversityIssue 5, Pages: 526-530(2008)
Wang Mei. Observation of circulating tumor cells in patients with lung carcinoma by real-time fluorescent quantitative-PCR approach before and after chemotherapy. [J]. Journal of Chongqing Medical University (5):526-530(2008)
Wang Mei. Observation of circulating tumor cells in patients with lung carcinoma by real-time fluorescent quantitative-PCR approach before and after chemotherapy. [J]. Journal of Chongqing Medical University (5):526-530(2008) DOI: 10.13406/j.cnki.cyxb.2008.05.017.
Observation of circulating tumor cells in patients with lung carcinoma by real-time fluorescent quantitative-PCR approach before and after chemotherapy
Objective:In order to develop a new standard of curative effect
this study was designed to track the number of CTCs in patients with lung cancer during chemotherapy.Methods:Samples of peripheral blood was taken from each lung cancer patients(n=32) on the day before chemotherapy as well as the third week after the chemotherapy cycle.The samples were subjected to real-time fqRT-PCR.Meanwhile the tumour size was determined by chest X-ray or computed tomograghy. Results:Compared to that of pre-chemotherapy
the expression level of CK19 in the patients significantly declined after chemotherapy(t=4.659
P=0.000 1).The level of CK19 mRNA in patients with SCLC was higher than that of patients with NSCLC(t=1.944
P=0.041).The change of CK19 mRNA correlated well with the type during the treatment.Relatively the shift of SCLC is more obvious(t=6.073
P=0.000 1).Conclusions:The real-time fluorescent quantitative-PCR approach is useful for measuring the relative number of CTCs in a patients’ peripheral blood to monitor the effectiveness of treatment
and for designing more comprehensive and reasonable therapeutic regimes at earlier dates for patients.
Fluctuation of circulating tumor cells in patients with lung cancer detected by real-time fluorescent quantitative-PCR approach before and after radiotherapy
Analysis of prognostic factors and clinical characteristics of patients with small cell lung cancer with malignant pericardial effusion
RESULTS OF EPIRUBICIN CONTAINING REGIMENS IN THE MANAGEMENT OF 70 CASES OF MALIGNANT TUMORS
AN ANALYSIS OF 114 PATIENTS WITH NASOPHARYNGEAL CARCINOMA TREATED BY COMBINED CHEMOTHERAPY AND RADIATION THERAPY
Glycogen assay for diagnosis of female genital Chlamydia trachomatis infection
Related Author
et al
Tonghua Mei
Hao Yang
白麟祥
时德
雷自重
何方志
陈晓品
Related Institution
Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Chongqing Medical University